Vanguard Group Inc. lessened its holdings in Fluidigm Co. (NASDAQ:FLDM) by 44.8% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 651,877 shares of the medical research company’s stock after selling 530,006 shares during the period. Vanguard Group Inc. owned about 2.23% of Fluidigm worth $2,634,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the company. Teachers Advisors LLC lifted its stake in shares of Fluidigm by 1.8% in the 2nd quarter. Teachers Advisors LLC now owns 56,662 shares of the medical research company’s stock worth $229,000 after purchasing an additional 999 shares during the period. American International Group Inc. lifted its stake in shares of Fluidigm by 7.1% in the 1st quarter. American International Group Inc. now owns 17,907 shares of the medical research company’s stock worth $102,000 after purchasing an additional 1,187 shares during the period. Geode Capital Management LLC lifted its stake in shares of Fluidigm by 1.5% in the 1st quarter. Geode Capital Management LLC now owns 218,321 shares of the medical research company’s stock worth $1,242,000 after purchasing an additional 3,311 shares during the period. Alliancebernstein L.P. lifted its stake in shares of Fluidigm by 18.4% in the 2nd quarter. Alliancebernstein L.P. now owns 45,700 shares of the medical research company’s stock worth $185,000 after purchasing an additional 7,100 shares during the period. Finally, Bank of New York Mellon Corp lifted its stake in shares of Fluidigm by 5.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 217,839 shares of the medical research company’s stock worth $880,000 after purchasing an additional 11,261 shares during the period. Hedge funds and other institutional investors own 93.33% of the company’s stock.
In other news, insider Levin Capital Strategies, L.P. bought 20,380 shares of the firm’s stock in a transaction on Wednesday, November 29th. The shares were bought at an average price of $5.71 per share, for a total transaction of $116,369.80. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. In the last 90 days, insiders have acquired 518,793 shares of company stock worth $2,502,504. 4.70% of the stock is owned by company insiders.
Fluidigm Co. (NASDAQ FLDM) opened at $5.70 on Wednesday. Fluidigm Co. has a one year low of $2.52 and a one year high of $8.69. The company has a current ratio of 3.02, a quick ratio of 2.46 and a debt-to-equity ratio of 5.00.
COPYRIGHT VIOLATION WARNING: This piece of content was posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.com-unik.info/2017/12/06/vanguard-group-inc-sells-530006-shares-of-fluidigm-co-fldm.html.
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.
What are top analysts saying about Fluidigm Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fluidigm Co. and related companies.